Jeonjinbio Co. Ltd (110020) — Capital Reinvestment Ratio

Latest as of September 2025: 0.03x

Jeonjinbio Co. Ltd (110020) has a Capital Reinvestment Ratio of 0.03x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩313.21 Million) in capital expenditures (₩10.04 Million). See debt-free asset ratio of Jeonjinbio Co. Ltd to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.03x
Capex / Operating Cash Flow

Operating Cash Flow

₩313.21 Million
KRW

Capital Expenditures

₩10.04 Million
KRW

Data as of

Sep 2025
Most recent filing

Jeonjinbio Co. Ltd Capital Reinvestment Ratio (2024–2024)

This chart tracks Jeonjinbio Co. Ltd's Capital Reinvestment Ratio across 1 annual periods. Check 110020 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Jeonjinbio Co. Ltd (2024–2024)

Year-by-year Capital Reinvestment Ratio for Jeonjinbio Co. Ltd from 2024 to 2024. For live market cap and broader valuation context, see Jeonjinbio Co. Ltd (110020) market capitalisation.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 0.13x ₩3.01 Billion ₩394.36 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow